Broglie M A, Soltermann A, Haile SR. Quality of life of oropharyngeal cancer patients with respect to treatment strategyand p16-positivity [J]. Laryngoscope, 2013(1):164.
|
Loewenthal M, Vitez E, Laban S. New aspects of current therapeutic strategies in oropharyngeal carcinoma:high-lights of the 2012 ASCO meeting [J]. Hals Nasen Ohrenheikunde, 2012, (11):951.
|
Adelstein D J, Ridge J A, Brizel D M. Transoral resection of pharyngeal cancer:summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia [J]. Head & Neck, 2012, (12):1681.
|
Vikulova IuV. The state-of-the-art of the diagnosis of oral and oropharyngeal cancer [J]. Vestnik Rentgenologii I Radiologii, 2012(3):51.
|
Perisanidis C, Sulzbacher I, Mittlb ck M. Survival of patients with pathologic T0N + oral and oropharyngeal cancer after neoadjuvant therapy and surgery:the minority report [J]. Oral Surgery Oral Medicine Oral Pathology Oral Radiology, 2013(3):293.
|
Haughey B H, Sinha P. Prognostic factors and survival unique to surgically treated p16 + oropharyngeal eancer [J]. Laryngoscope, 2012, (Suppl 2):S13.
|
许德斌, 陈文宽, 郭朱明. 口咽鳞状细胞癌患者治疗及预后因素分析 [J]. 中国耳鼻咽喉头颈外科, 2011(6):284.
|
Wu Y, Posner M R, Schumaker L M. Novel biomarker panel predicts prognosis in human papillomavirus-negative oropharyngeal cancer:an analysis of the TAX 324 trial [J]. Cancer, 2012(7):1811.
|
Kim T W, Choi S Y, Ko Y H. The Prognostic Role of p16 Expression in Tonsil Cancer Treated by Either Surgery or Radiation [J]. Clin Exp Otorhinolaryngol, 2012(4):207.
|